Position in JNJ
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$7,754,719
+$238,434 QoQ
Shares Held
30,534
-0.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.52%
of 13F equity value
Holder Rank
#1,273
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JFS WEALTH ADVISORS, LLC holds $17,102,053 across 16 Drug Manufacturers - General names. JNJ ranks #1 (45.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
30,534 | $7,754,719 | |
| 2 | ABBV |
AbbVie Inc.
|
10,506 | $2,643,729 | |
| 3 | MRK |
Merck & Co., Inc.
|
18,599 | $2,389,971 | |
| 4 | LLY |
ELI LILLY & Co
|
901 | $1,080,686 | |
| 5 | PFE |
Pfizer Inc
|
40,840 | $983,427 | |
| 6 | NVS |
Novartis AG
|
4,893 | $766,830 | |
| 7 | AZN |
Astrazeneca PLC
|
2,497 | $473,481 | |
| 8 | AMGN |
Amgen Inc
|
1,004 | $363,568 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,754,719 | 30,534 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $7,516,285 | 30,749 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $6,384,821 | 30,852 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $5,798,268 | 31,271 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $4,626,339 | 30,287 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $5,106,545 | 30,792 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $4,380,105 | 30,287 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $4,962,439 | 30,621 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $2,990,579 | 20,461 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $2,497,820 | 15,790 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $2,609,250 | 16,647 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $2,591,835 | 16,641 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $2,703,769 | 16,335 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $2,648,020 | 17,084 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $3,049,508 | 17,263 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,972,661 | 18,197 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $3,239,202 | 18,248 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $3,256,246 | 18,373 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $3,168,558 | 18,522 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $3,048,312 | 18,875 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $2,446,883 | 14,853 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $2,514,719 | 15,301 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $2,453,396 | 15,589 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $2,308,533 | 15,506 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $2,194,953 | 15,608 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $1,998,683 | 15,242 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||